📰 Seqirus Pty News
Seqirus Pty News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Seqirus Pty. Real-time updates on events, politics, business and more.
January 20, 2022
Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark S
January 20, 2022
Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd
January 20, 2022
Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark S
January 20, 2022
Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark S
January 20, 2022
Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark S
October 1, 2021
Mumbai: Global pharma company, Glenmark Pharmaceuticals Limited, has recently announced that the company has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13...
April 26, 2021
Glenmarks Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age News provided by Share this article Share this article The launch will ensure much-needed access to a novel fixed-dose combination nasal spray for this chronic condition This marks Glenmarks first innovative product approval in the European Union MUMBAI, India, April 26, 2021 /PRNewswire/ -- Glenmark Pharmaceuticals Limited, a research-led, global integrat...
February 22, 2021
Glenmarks Ryaltris®- innovative single nasal spray, ready to market in Russia MUMBAI, India, Feb. 22, 2021 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S A, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris® Nasal Spray - a novel fixed-dose combination nasal spray. This paves the way for commercial...
December 23, 2020
Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray Posted On: 2020-12-22 20:36:41 (Time Zone: Arizona, USA) Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris™ across ...
December 23, 2020
Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe ANI | Updated: Dec 23, 2020 11:14 IST Mumbai (Maharashtra) [India] December 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, has en...